| Literature DB >> 28805701 |
Chao Huang1,2, Zhongkai Zhu3, Xiyue Cao4,5, Xingfu Chen6, Yuping Fu7,8, Zhengli Chen9,10, Lixia Li11,12, Xu Song13,14, Renyong Jia15, Zhongqiong Yin16,17, Gang Ye18, Bin Feng19, Yuanfeng Zou20,21.
Abstract
Sijunzi Decoction (SJZD) is a formula used for the treatment of spleen deficiency and gastrointestinal diseases in Traditional Chinese Medicine. Polysaccharides are reported to be the main components of SJZD responsible for its bio-functions. However, highly purified and clearly characterized polysaccharides from SJZD are not well described. Here we obtained a purified polysaccharide (SJZDP-II-I) from SJZD using ion exchange chromatography and gel filtration. Structure analysis by FT-IR and NMR identified SJZDP-II-I as a typical pectic polysaccharide with homogalacturonan and rhamnogalacturonan type I regions and arabinogalactan type I and II as side chains. In vitro studies indicated that SJZDP-II-I treatment could significantly enhance the total antioxidant capacity of SW480 cells, resulting from the promoted expressions of antioxidant enzymes and their master regulator PGC-1α, which would be valuable for further research and applications.Entities:
Keywords: SJZD; Sijunzi Decoction; antioxidant defense; oxidative stress; pectic polysaccharide
Mesh:
Substances:
Year: 2017 PMID: 28805701 PMCID: PMC6152311 DOI: 10.3390/molecules22081341
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The carbohydrate elution profiles were monitored using the phenol–sulfuric acid assay (A490 is the absorbance at 490 nm). (A) Ion exchange chromatography elution profile of SJZDP: (a) SJZDP-I and (b) SJZDP-II; (B) Gel filtration elution profile of SJZDP-I: (c) SJZDP-I-I and (d) SJZDP-I-II; (C) Gel filtration elution profile of SJZDP-II: (e) SJZDP-II-I.
Monosaccharide compositions (mol %) and Mw of polysaccharide fractions SJZDP-I-I, SJZDP-I-II and SJZDP-II-I, isolated from SJZDP.
| SJZDP-I-I | SJZDP-I-II | SJZDP-II-I | |
|---|---|---|---|
| Ara a | 51.2 | 18.9 | 32.8 |
| Rha a | 2.3 | 1.7 | 5.0 |
| Fuc a | 2.1 | n.d. | 0.4 |
| Xyl a | n.d. | 2.4 | 0.4 |
| Man a | 3.7 | 1.4 | 0.4 |
| Gal a | 23.6 | 4.7 | 40.5 |
| Glc a | 11.2 | 66.9 | 1.5 |
| GlcA a | 0.8 | n.d. | 1.5 |
| GalA a | 5.2 | 4.0 | 17.4 |
| Mw (kDa) | 351.0 | 16.9 | 171.9 |
n.d. not detected. a mol % related to total content of the monosaccharides arabinose (Ara), rhamnose (Rha), fucose (Fuc), mannose (Man), galactose (Gal), glucose (Glc), Glucuronic acid (GlcA) and Galacturonic acid (GalA).
The glycosidic linkage (mol %) present in the fraction SJZDP-II-I isolated from SJZDP.
| Linkage Type | mol % | |
|---|---|---|
| Ara | T | 22.7 |
| 1→5 | 3.7 | |
| 1→3,5 | 6.4 | |
| Rha | T | 0.4 |
| 1→2 | 1.8 | |
| 1→2, 4 | 2.8 | |
| Gal | T | 2.4 |
| 1→4 | 10.7 | |
| 1→3 | 2.2 | |
| 1→6 | 5.1 | |
| 1→3, 6 | 20.1 | |
| Glc | T | 1.5 |
| GlcA | T | 1.5 |
| GalA | T | 0.9 |
| 1→4 | 16.5 |
Figure 2FT-IR spectra of fraction SJZDP-II-I.
Figure 3The 1H- and 13C-NMR spectra of polysaccharide fraction SJZDP-II-I. (A) 1H-NMR spectra of SJZDP-II-I; (B) 13C-NMR spectra of SJZDP-II-I.
Figure 4SJZDP-II-I treatment didn’t affect the proliferation of SW480 cells. Quantification shows no enhancement of cell proliferation and cytotoxicity of SJZDP-II-I in SW480 cells, with a concentration up to 40 µg/mL. Error bars indicate SD. Data are shown as mean ± SD of triplicates of one experiment, and the experiment was repeated 3 times.
Figure 5SJZDP-II-I treatment promoted the expression of antioxidant defense genes. (A) Quantification showed an increase of total antioxidant capability in SW480 cells after SJZDP-II-I treatment. Error bars indicated SD. * p < 0.05. N = 3; (B) In vitro assay displayed little antioxidant capacity of SJZDP-II-I when it was compared with Vitamin E. N = 3; (C) qRT-PCR showed robust increased mRNA levels of PGC-1α and antioxidant enzymes after SJZDP-II-I treatment in SW480 cells. Error bars indicated SD. * p < 0.05, ** p < 0.01, *** p < 0.001. N = 3.
qRT-PCR primers for antioxidant defense genes.
| SOD1 | Fr 5′-CAAGCGGTGAACCAGTTGTG-3′ |
| Rv 5′-TGAGGTCCTGCACTGGTAC-3′ | |
| SOD2 | Fr 5′-GCCTGCACTGAAGTTCAATG-3′ |
| Rv 5′-ATCTGTAAGCGACCTTGCTC-3′ | |
| Catalase | Fr 5′-ACCCTCTTATACCAGTTGGC-3′ |
| Rv 5′-GCATGCACATGGGGCCATCA-3′ | |
| GSTP1 | Fr 5′-ATGCCACCATACACCATTGTC-3′ |
| Rv 5′-GGGAGCTGCCCATACAGAC-3′ | |
| PGC-1α | Fr 5′-CTCCCTGTGGATGAAGACGG-3′ |
| Rv 5′-GCAAATCACAATCACAGGAT-3′ |
SOD, Superoxide dismutase; GSTP, Glutathione S-transferase Pi; PGC-1a, Peroxisome proliferator-activated receptor gamma coactivator 1-alpha.